Neuroleptic malignant syndrome-like reaction precipitated by antipsychotics in a patient with gamma-butyrolactone withdrawal.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 21817917.
- Also identified by DOI 10.1097/ADM.0b013e3182236730.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report the case of a patient with chronic abuse of gamma-butyrolactone (GBL, 3 bottles per week for 4 months), who in the course of the management of acute agitation and hallucinations developed symptoms compatible with both neuroleptic malignant syndrome and GBL withdrawal symptoms.Some GHB withdrawal symptoms are similar to those of neuroleptic malignant syndrome, and the administration of antipsychotics might worsen the neurological condition of patients. So, it seems important to rapidly detect drugs taken by patients with mental agitation, to optimize management and minimize complications related to drugs.
Medical subject headings
- 4-Butyrolactone
- Antipsychotic Agents
- Hallucinations
- Neuroleptic Malignant Syndrome
- Psychomotor Agitation
- Solvents
- Substance Withdrawal Syndrome
- Substance-Related Disorders